This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Randomized test-treatment studies with an outlook on adaptive designs
BMC Medical Research Methodology Open Access 01 June 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allison, M. Biomarker-led adaptive trial blazes a trail in breast cancer. Nat Biotechnol 28, 383–384 (2010). https://doi.org/10.1038/nbt0510-383
Issue Date:
DOI: https://doi.org/10.1038/nbt0510-383
This article is cited by
-
Randomized test-treatment studies with an outlook on adaptive designs
BMC Medical Research Methodology (2021)
-
Master Protocol for squamous cell lung cancer readies for launch
Nature Biotechnology (2014)
-
Reinventing clinical trials
Nature Biotechnology (2012)
-
Can cancer clinical trials be fixed?
Nature Biotechnology (2011)
-
Turning the tide in lung cancer
Nature Biotechnology (2010)